Monthly Archives: February 2013
Bayer Fights Against Federal Multi-District Litigation Consolidation
Although Bayer petitioned the New Jersey courts to consolidate Mirena IUD cases, Bayer is now opposing consolidation in the federal courts. This latest battle began when plaintiff’s counsel filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) … Read More
Forecasting Lawsuits for Medtronic Medical Devices
Serious complaints are stemming from Medtronic Infuse bone graft patients. Although Medtronic sales spiked at $800 million as recently as 2011, it appears a litany of Medtronic lawsuits are poised to launch. Complications tied to Medtronic products are deadly. They’ve … Read More
Companies to Pay $688 from Cholesterol Drug Lawsuits
The third largest drug company, Merck, and fellow pharmaceutical partner, Scherling-Plough had agreed to pay out $688 million dollars to their investors after not coming forward with an unfavorable study of their top selling cholesterol drugs, Zetia and Vytorin. Upon … Read More
Yaz Lawsuits Increase after FDA enforces new label
The number of lawsuits leveled against the PMDD medication company Yaz has risen significantly after the Federal Drug Administration ordered the company to place a stronger warning label on their product in April of 2012. The stronger warning label states … Read More
Stryker Recall Costly for the Orthopedic Manufacturer
Stryker Corporation said on Wednesday that a hip implant recall that began in June of 2012 will cost up to $390 million for treatment, new surgeries, lawsuits and insurance payments. The company said that is has raised the low end … Read More